Vanguard Capital Management 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-29 4:38 pm Purchase | 2026-03-31 | 13G | AGIOS PHARMACEUTICALS INC AGIO | Vanguard Capital Management | 3,088,169 5.270% | 3,088,169 (New Position) | Filing |